SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-021104
Filing Date
2022-08-04
Accepted
2022-08-04 16:32:40
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ngm-20220630.htm   iXBRL 10-Q 1668934
2 EX-10.1 ngm-20220630x10qex101.htm EX-10.1 1035617
3 EX-31.1 ngm-20220630x10qex311.htm EX-31.1 11196
4 EX-31.2 ngm-20220630x10qex312.htm EX-31.2 10954
5 EX-32.1 ngm-20220630x10qex321.htm EX-32.1 8546
11 image_0a.jpg GRAPHIC 84358
12 image_1a.jpg GRAPHIC 155079
13 image_26a.jpg GRAPHIC 350942
14 image_27a.jpg GRAPHIC 157039
  Complete submission text file 0001628280-22-021104.txt   9158850

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngm-20220630.xsd EX-101.SCH 40393
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ngm-20220630_cal.xml EX-101.CAL 51871
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ngm-20220630_def.xml EX-101.DEF 192520
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngm-20220630_lab.xml EX-101.LAB 552252
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngm-20220630_pre.xml EX-101.PRE 349143
61 EXTRACTED XBRL INSTANCE DOCUMENT ngm-20220630_htm.xml XML 1143089
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38853 | Film No.: 221137188
SIC: 2834 Pharmaceutical Preparations